Evercore Cuts Danaher (NYSE:DHR) Price Target to $225.00

Danaher (NYSE:DHR) had its price objective cut by Evercore from $254.00 to $225.00 in a report published on Monday morning,MarketScreener reports. They currently have an outperform rating on the conglomerate’s stock.

Other equities research analysts also recently issued reports about the stock. Argus set a $265.00 price target on shares of Danaher in a research note on Wednesday, January 14th. Robert W. Baird set a $251.00 price target on shares of Danaher in a research note on Thursday, January 29th. Guggenheim lifted their price objective on shares of Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a report on Friday, January 2nd. TD Cowen restated a “buy” rating on shares of Danaher in a report on Wednesday, January 7th. Finally, Wells Fargo & Company lifted their price objective on shares of Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. Eighteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $251.35.

Danaher Price Performance

Danaher stock opened at $196.34 on Monday. The company’s 50 day simple moving average is $202.14 and its 200-day simple moving average is $214.46. The company has a market capitalization of $138.95 billion, a price-to-earnings ratio of 38.96, a price-to-earnings-growth ratio of 2.59 and a beta of 0.95. Danaher has a 1 year low of $171.00 and a 1 year high of $242.80. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. The business had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The business’s revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the firm earned $2.14 EPS. As a group, equities research analysts expect that Danaher will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. This is an increase from Danaher’s previous quarterly dividend of $0.32. The ex-dividend date is Friday, March 27th. Danaher’s dividend payout ratio (DPR) is presently 31.75%.

Insider Buying and Selling at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares in the company, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 11.10% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in DHR. Norges Bank acquired a new position in Danaher during the 4th quarter worth approximately $2,177,106,000. Viking Global Investors LP grew its holdings in Danaher by 543.9% during the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock worth $574,351,000 after acquiring an additional 2,455,994 shares in the last quarter. Massachusetts Financial Services Co. MA grew its holdings in Danaher by 104.7% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock worth $991,923,000 after acquiring an additional 2,216,789 shares in the last quarter. Generation Investment Management LLP grew its holdings in Danaher by 34.0% during the 3rd quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock worth $1,319,354,000 after acquiring an additional 1,689,020 shares in the last quarter. Finally, Wellington Management Group LLP grew its holdings in Danaher by 11.2% during the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock worth $3,451,380,000 after acquiring an additional 1,517,904 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Trending Headlines about Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Evercore ISI kept an Outperform rating on DHR and added the shares to its “Tactical Outperform” list — a vote of confidence from a major research house that can support demand for the stock despite a lower target. Evercore article
• Positive Sentiment: Major analysts (Jefferies, Wolfe) maintained buy/outperform stances on DHR even after adjusting models — indicating continued conviction in Danaher’s long‑term fundamentals and M&A strategy. Jefferies Wolfe
• Neutral Sentiment: Sector context: a recent healthcare roundup notes the industry holding up versus the broader market and highlights companies with solid fundamentals — a neutral tailwind for Danaher given its exposure to diagnostics and life‑science tools. Healthcare sector article
• Negative Sentiment: Multiple firms cut DHR price targets this week (Jefferies: $265 → $240; Wolfe: $260 → $230; Evercore: $254 → $225). Lower targets narrow upside and reflect more conservative near‑term expectations, which can cap gains even with buy/outperform ratings. Jefferies Wolfe Evercore
• Negative Sentiment: An investor‑rights firm is investigating the proposed sale of Masimo to Danaher, probing whether the $180/share offer and the process were adequate — a potential legal/transactional headwind that could delay or complicate the deal and create near‑term uncertainty. Masimo investigation

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.